Blue Owl Capital Holdings LP Context Therapeutics Inc. Transaction History
Blue Owl Capital Holdings LP
- $194 Million
- Q1 2025
A detailed history of Blue Owl Capital Holdings LP transactions in Context Therapeutics Inc. stock. As of the latest transaction made, Blue Owl Capital Holdings LP holds 7,367,906 shares of CNTX stock, worth $5.08 Million. This represents 2.32% of its overall portfolio holdings.
Number of Shares
7,367,906
Previous 6,357,928
15.89%
Holding current value
$5.08 Million
Previous $6.29 Million
28.6%
% of portfolio
2.32%
Previous 2.69%
Shares
4 transactions
Others Institutions Holding CNTX
# of Institutions
47Shares Held
79MCall Options Held
0Put Options Held
0-
Bio Impact Capital LLC Cambridge, MA14.7MShares$10.1 Million1.66% of portfolio
-
Avidity Partners Management LP Dallas, TX7.48MShares$5.16 Million1.03% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.42MShares$5.12 Million0.16% of portfolio
-
Nextech Invest, Ltd. Zurich, V87.42MShares$5.12 Million1.06% of portfolio
-
Nextech Invest Ag7.42MShares$5.12 Million1.37% of portfolio
About Context Therapeutics Inc.
- Ticker CNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,966,100
- Market Cap $11M
- Description
- Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...